Centers for Disease Control and Prevention. Interpretation and use of the Western blot assay for serodiagnosis
of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep.1989;38(suppl 7):1-7.
Hausler Jr WJ. Report of the Third Consensus Conference on HIV testing sponsored by
the Association of State and Territorial Public Health Laboratory Directors. Infect Control Hosp Epidemiol.1988;9:345-349.
Consortium for Retrovirus Serology. Serological diagnosis of human immunodeficiency virus infection by
Western blot testing. JAMA.1988;260:674-679.
Dodd RY, Fang CT. The Western immunoblot procedure for HIV antibodies and its interpretation. Arch Pathol Lab Med.1990;114:240-245.
Revised Recommendations for the Prevention of Human Immunodeficiency
Virus (HIV) Transmission by Blood and Blood Products . Bethesda, Md: Center for Biologics Evaluation and Research, Food
and Drug Administration; April 23, 1992.
Centers for Disease Control and Prevention. Interpretive criteria used to report Western blot results for HIV-1
antibody testing—United States. MMWR Morb Mortal Wkly Rep.1991;40:692-695.
Healey DS, Bolton WV. Apparent HIV-1 glycoprotein reactivity on Western blot in uninfected
blood donors. AIDS.1993;7:655-658.
Sayre KR, Dodd RY, Tegtmeier G, Layug L, Alexander SS, Busch MP. False-positive human immunodeficiency virus type 1 Western blot tests
in noninfected blood donors. Transfusion.1996;36:45-52.
Bukrinsky MI, Chaplinskas SA, Syrtsev VA, Bravkilene LA, Phillipov YV. Reactivity to gag- and env-related proteins in immunoblot assay is
not necessarily indicative of HIV infection. AIDS.1988;2:405-406.
Zuck TF, Thomson RA, Schreiber GB.
et al. The Retrovirus Epidemiology Donor Study (REDS): rationale and methods. Transfusion.1995;35:944-951.
Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency
virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol.1994;32:292-300.
McFarland W, Rawal B, Kellogg T.
et al. Estimating HIV incidence among anonymous test seekers in San Francisco
using a dual EIA antibody test strategy. In: Abstracts of the Infectious Disease Society of America 35th Annual
Meeting; September 13-16, 1997; San Francisco, Calif.
Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan
areas. Am J Public Health.1996;86:642-654.
Weinstock HS, Sweeney S, Steinberg S, Gwinn M. HIV seroincidence among persons attending STD clinics in the United
States, 1988-1995. In: Program and abstracts of the XI International Conference on AIDS;
July 7-12, 1996; Vancouver, British Columbia. Abstract Tu.C.2409.
Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections: the Retrovirus
Epidemiology Donor Study. N Engl J Med.1996;334:1685-1690.
Busch MP, Satten GA, Herman SA.
et al. HIV plasma RNA for confirmation of HIV-1 p24 Ag/anti-HIV reactivity
in seroconverting donors. Transfusion.1996;36(suppl):41S.
Piatak Jr M, Saag MS, Yang LC.
et al. High levels of HIV-1 in plasma during all stages of infection determined
by competitive PCR. Science.1993;259:1749-1754.
Langedijk JP, Vos WF, van Doornum GJ, Rotman HA, Meloen RH, Huisman JG. Identification of cross-reactive epitopes recognized by HIV-1 false-positive
Fenouillet E, Blanes N, Gluckman JC. Gp160 of commercial HIV Western blots is not gp160env: should criteria
for seropositivity be revised? AIDS.1991;5:770.
Schwartz DH, Mazumdar A, Winston S, Harkonen S. Utility of various commercially available human immunodeficiency virus
(HIV) antibody diagnostic kits for use in conjunction with efficacy trials
of HIV-1 vaccines. Clin Diagn Lab Immunol.1995;2:268-271.
Centers for Disease Control and Prevention. Update: HIV-2 infection among blood and plasma donors—United
States, June 1992-June 1995. MMWR Morb Mortal Wkly Rep.1995;42:603-606.
Centers for Disease Control and Prevention. Identification of HIV-1 Group O infection—Los Angeles County,
California, 1996. MMWR Morb Mortal Wkly Rep.1996;45:561-564.
Wallace EL, Surgenor DM, Hao HS, An J, Chapman RH, Churchill WH. Collection and transfusion of blood and blood components in the United
States, 1989. Transfusion.1993;33:139-144.
Sabino EC, Delwart E, Lee TH, Mayer A, Mullins JI, Busch MP. Identification of low-level contamination of blood as basis for detection
of human immunodeficiency virus (HIV) DNA in anti-HIV-negative specimens. J Acquir Immune Defic Syndr.1994;7:853-859.
Brown AE, Jackson B, Fuller SA, Sheffield J, Cannon MA, Lane JR. Viral RNA in the resolution of human immunodeficiency virus type 1
diagnostic serology. Transfusion.1997;37:926-929.
Hausler Jr WJ, Getchell JP. Report of the Fourth Consensus Conference on HIV testing sponsored
by the Association of State and Territorial Public Health Laboratory Directors
(ASTPHLD). Infect Control Hosp Epidemiol.1989;10:354-367.